Last deal

Amount

Post-IPO Equity

Stage

01.02.2007

Date

3

all rounds

$85.1M

Total amount

Financing round

General

About Company
Coley Pharma develops therapeutics to boost immune system against cancer, asthma, allergies, and autoimmune disorders.

Industry

Sector :

Subsector :

Also Known As

CpG ImmunoPharmaceuticals

founded date

01.01.1997

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Formerly known as CpG ImmunoPharmaceuticals, Inc., Coley Pharmaceutical Group was founded in 1997 and is based in Wellesley, Massachusetts. The company focuses on researching and developing Toll-like receptor drugs that modulate the immune system for the treatment of cancer, infectious diseases, asthma, and allergies. In 2007, it became a subsidiary of Pfizer Inc.
Similar Companies
1000
VentiRx Pharmaceuticals

VentiRx Pharmaceuticals

VentiRx Pharmaceuticals develops medicines for cancer, respiratory, and autoimmune diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Seattle, WA, USA

total rounds

4

total raised

$104.5M
Tonix Pharmaceuticals Holding

Tonix Pharmaceuticals Holding

Tonix Pharmaceuticals is developing innovative therapies and vaccines to improve population health.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

New York, NY, USA

total rounds

18

total raised

$316.74M
Tolero Pharmaceuticals

Tolero Pharmaceuticals

Tolero Pharmaceuticals develops novel therapeutics for cancer and other life-threatening diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

Salt Lake City, UT, USA

total rounds

4

total raised

$25.93M
Funxional Therapeutics

Funxional Therapeutics

Funxional Therapeutics is a pharmaceutical company that develops products to treat various diseases and disorders.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cambridge, UK

total rounds

2

total raised

$12.2M
M&A Details
1

Transaction name

Acquired by

Pfizer

announced date

16.11.2007

price

$164M

Financials

Funding Rounds
7
3

Number of Funding Rounds

$85.1M

Money Raised

Their latest funding was raised on 01.02.2007. Their latest investor Techno Venture Management. Their latest round Post-IPO Equity

Date 
Funding Round 
Investors 
Money Raised 
Lead 
16.03.2005
1
$10M
14.09.2004
2
$25.2M
Thuja Capital

Thuja Capital

Thuja Capital is a Dutch venture capital firm that invests in early-stage medical product innovations.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Utrecht, Netherlands

count Of Investments

51

count Of Exists

10
Co-Investors
Investors
8
3

Number of lead investors

8

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Series E, Series F, Series G, Venture - Series Unknown
No
Series B
Yes
Series F, Series G
Techno Venture Management

Techno Venture Management

Techno Venture Management is a venture capital and private equity firm focused on the healthcare industry.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Health Care

Location

Boston, MA, USA

count Of Investments

73

count Of Exists

17
Alafi Capital

Alafi Capital

Alafi Capital is a private venture capital firm specializing in healthcare investments.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Health Care

Location

San Francisco, CA, USA

count Of Investments

17

count Of Exists

5
Thomas, McNerney & Partners

Thomas, McNerney & Partners

Thomas, McNerney & Partners is a healthcare venture capital firm.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Medical Device, Health Care, Venture Capital

Location

Stamford, CT, USA

count Of Investments

43

count Of Exists

15

People

Employee Profiles
9
Albert Bourla

Albert Bourla

CEO and Chairman

Steve Bernitz

Steve Bernitz

SVP, Business & Commercial Development

Deanna Petersen

Deanna Petersen

Vice President of Business Development

Madhavan Balachandran

Madhavan Balachandran

Engineering, Manufacturing, and Consulting

Julie Lekstrom Himes

Julie Lekstrom Himes

Responsible for all clinical programs

Susan Hager

Susan Hager

Vice President, Corporate Communications, Investor Relations and Corporate Development

Activity

Recent News
0